2Ahmed A, Perry G J, Fleg J L, et al. Outcomes in ambuLatory chronic systolic and diastoLic heart faiLure: A propensity score anaLysis[J]. Am Heart J, 2006, 152: 956.
3Zile M R, Brutsaert D L. New concepts in diastoLic dysfunction and diastoLic heart faiLure: part Ⅰ: Diagnosis, prognosis, and measurements of diastoLic function [ J ]. CircuLation, 2002, 105: 1387,.
4Mcdonagh T, Robb S D, Murdoch D R, et al. BiochemicaL detection of Left ventricuLar dysfunction in systoLic dysfunction[J]. Lancet, 1998, 351: 9.
5Lubien E, PemariaA, Krishnaaswamy P, et al. UtiLity of B - natriuretic peptide im detecting diastoLic dysfunction: comparison with DoppLer velocity recordings [J]. CircuLation, 2002, 105: 595.
8Harrison A, Morrison L K, Krishnaaswamy P, et al. B- type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J]. Am Emerg Med, 2002, 39: 131.
9Morrow D, DeLemos J A, Sabatine M S, et al. Detection of cardiac neurohorrnonaL activation compLements cardic troponin for predicting recurrent events in UAZNSTEMI: prognostic utiLity of BNP in TACTICS - TIMI18[J]. J Am CoLL CardiaL, 2002, 40: 437.
3[1]Maeda K,Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J,1998,135 : 825-832.
4[2]Maisel AS,Krishnaswamy P, Richards M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347:161-167.
5[3]Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet, 1998,351:9-13.
6[5]Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels . Jpn Heart J, 2000,41: 205-214.
7[6]Cowie MW.BNP: soon to become a routine measure in the care of patients with heart failure? Heart,2000,83:617-618.
8[7]Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med, 2002, 39: 131-138.
9[8]Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriureric peptide in cardiology.J Lab Clin Med, 1999, 134:437-444.
10Muller C. Brain natriuretic peptide for Acute Shortness of breath EvaLuation: a randomized comparison (BASEL). Presented at the ESC Congress 2003; August 30 - September 3, 2003; Vienna, Austria. Hot Line I: Medical Treatment/Heart Failure, Presentation # 84.
6Wozakowska - kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation[J]. Am J Cardiol, 2004, 93(12): 1555.
7Ohta Y, Shimada T. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation[J]. Can J cardiol, 2001, 17(4): 415.
8A Rashidi. Mechanism of high brain natriuretic peptide in patients with atrial fibrillation [ J ]. Am J Cardiol, 2004, 93 (5): 670.
9Watanabe M, Murakami M, Furukawa H, et al. Decreased plasma brain natriuretic peptide levels after a successful maze procedure [J].J Heart Valve Pis, 2003, 12(3) : 287.
10Sudoh T, Kangawa K, Minamino N, et al. A new natfiuretic peptide in porcine brain [J]. Nature, 1988,332( 1 ) :78-81.
